GlassScriptPhysician profile
Andrew James Brenyo
NPI 1760667737
$240,707.96
in general payments reported to CMS, 2019-2025
35 companies · $20K in 2025
The $20K reported for 2025 was more than what 89% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $70K · 2020: $71K · 2021: $13K · 2022: $34K · 2023: $6,732 · 2024: $26K · 2025: $20K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $17K · Consulting Fee: $15K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $9,000 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,000 · Food and Beverage: $5,167.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $17,150.74 |
| Consulting Fee | $14,860.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $9,000.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,000.00 |
| Food and Beverage | $5,167.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $101,545.50 | 2019-2022 | |
| Biosense Webster, INC. | $37,308.98 | 2019-2023 | Carto 3 |
| Biotronik INC. | $34,152.73 | 2020-2025 | Selectra, Solia, Amvia Edge |
| Abbott Laboratories | $23,552.09 | 2019-2025 | Ensite, Tacticath Ablation Catheter, Sensor Enabled, Sensitherm Multi |
| Acutus Medical, INC. | $18,065.83 | 2019-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $13,507.22 | 2019-2025 | Lifevest |
| Terumo Medical Corporation | $4,341.55 | 2019-2020 | |
| Biosig Technologies, INC. | $3,328.46 | 2019 | |
| Boston Scientific Corporation | $1,265.48 | 2019-2025 | Watchman Flx, Watchman Access System |
| Cordis US Corp. | $1,043.64 | 2024-2025 | Mynx Control Venous, Mynx Venous Vcd |
| Cardiva Medical, INC. | $479.24 | 2021-2023 | Cardiva Vascade 6/7f Vcs |
| Atricure, INC. | $391.41 | 2021-2023 | |
| Cvrx, INC. | $361.03 | 2021-2024 | Barostim Neo System |
| E.R. Squibb & Sons, L.L.C. | $231.48 | 2020-2025 | Camzyos, Eliquis |
| Pfizer INC. | $226.33 | 2019-2024 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $204.74 | 2019-2025 | |
| Cardiovascular Systems INC. | $178.55 | 2019-2023 | Diamondback Coronary |
| Astrazeneca Pharmaceuticals LP | $81.52 | 2019-2021 | |
| Abiomed | $51.76 | 2019-2020 | |
| Davol INC. | $45.85 | 2020 | |
| Kestra Medical Technology Services, INC. | $34.92 | 2022 | |
| Amgen INC. | $33.09 | 2021-2022 | |
| Amarin Pharma, INC. | $29.98 | 2019-2020 | |
| Lexicon Pharmaceuticals, INC. | $29.80 | 2024 | |
| Tactile Systems Technology INC | $26.24 | 2023 | Entre Plus, Flexitouch Plus |
| Janssen Pharmaceuticals, INC | $25.50 | 2022 | |
| Medtronic, INC. | $23.02 | 2024 | Pulseselect |
| Acist Medical Systems, INC. | $21.57 | 2025 | |
| Medtronic Vascular, INC. | $19.35 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.33 | 2023 | |
| Actelion Pharmaceuticals US, INC. | $19.30 | 2023 | Uptravi, Opsumit |
| Sanofi-Aventis U.S. LLC | $19.10 | 2019 | |
| Teleflex LLC | $16.45 | 2024 | Guideliner |
| Cleerly, INC. | $15.91 | 2024 | Cleerly Labs, Cleerly Ischemia |
| Cardinal Health 200 LLC | $11.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Brenyo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.